UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 10 | October 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 4
April-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2404C34


Registration ID:
538313

Page Number

m257-m267

Share This Article


Jetir RMS

Title

FORMULATION AND EVALUATION OF ASHWAGANDHA HERBAL RESPULES

Abstract

Withania somnifera (Ashawagandha) is very revered herb of the Indian Ayurvedic system of medicine as a Rasayana (tonic). It is used for various kinds of disease processes. COPD is a chronic pulmonary disease, characterized by partially reversible chronic airflow obstruction, inflammation, and small-airway remodeling. It is one of the diseases included in WHO Global Action Plan for the Prevention and Control of Non communicable Diseases (NCDs). The risk factors include exposure to tobacco smoke, air pollution, and occupational pollution. COPD has no cure until now. Moreover, due to the increasing ambient air pollution people are at higher risk of developing COPD. Numerous studies have demonstrated that increased oxidative stress and inflammation are the two major driving mechanisms in COPD progression. Extensive studies have been carried out till now on WS, showing its diverse therapeutic properties, namely, immune modulatory (both immunosuppressive and immune-stimulatory), neuro modulatory, anticancer, cognition- promoting, antifungal, antibacterial, antidepressant. The objectives of the present study are as follows: 1) to study the add-on effect of WS on COPD patient’s pulmonary functioning, quality of life, and exercise tolerance; (2) to find its mechanism of action by evaluating its antioxidant or anti- inflammatory potential; correlating it with lung functioning parameters; and in silico identification of potential inhibitors of MPO and IL-6 proteins; and (3) to identify the phytochemicals present in WS root extract and in silico analyzing their inhibitory activity against ACE-2, thus evaluating its antiviral potential.

Key Words

Respules, Ashwagandha, Nebulizer, Anti inflammatory Activity.

Cite This Article

"FORMULATION AND EVALUATION OF ASHWAGANDHA HERBAL RESPULES", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 4, page no.m257-m267, April-2024, Available :http://www.jetir.org/papers/JETIR2404C34.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"FORMULATION AND EVALUATION OF ASHWAGANDHA HERBAL RESPULES", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 4, page no. ppm257-m267, April-2024, Available at : http://www.jetir.org/papers/JETIR2404C34.pdf

Publication Details

Published Paper ID: JETIR2404C34
Registration ID: 538313
Published In: Volume 11 | Issue 4 | Year April-2024
DOI (Digital Object Identifier):
Page No: m257-m267
Country: Shrigonda, Maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00079

Print This Page

Current Call For Paper

Jetir RMS